Varinder Singh

Northwell Health

Papers

4

Total Citations

74

H-Index

3

About

Varinder Singh is a leading figure in the field of minimally invasive and hybrid coronary revascularization, whose work has reshaped surgical approaches to multi-vessel coronary artery disease. His research focuses on optimizing outcomes for patients with complex coronary lesions, particularly through the development and long-term assessment of hybrid coronary revascularization (HCR) and minimally invasive direct coronary artery bypass (MIDCAB). Singh’s landmark 2018 study on short- and intermediate-term outcomes of HCR for double-vessel disease (43 citations) provided critical early evidence for the safety and efficacy of this combined surgical-percutaneous approach. He further advanced the field with a direct comparison of MIDCAB versus percutaneous intervention for isolated left anterior descending (LAD) stenosis (24 citations), demonstrating the superiority of the minimally invasive surgical technique. His comprehensive 25-year review of the MIDCAB paradigm, analyzing over 2,200 patients, and his recent ten-year outcomes study of HCR (2024) solidify his reputation as a pioneer in durable, less invasive cardiac surgery. Singh’s work continues to guide clinical decision-making and set benchmarks for long-term patency and patient recovery.

Research Focus

Key Achievements

3
H-Index
4
Papers
74
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Short- and intermediate-term outcomes of hybrid coronary revascularization for double-vessel disease
43 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Northwell Health

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago